PRESS RELEASE published on 01/23/2025 at 22:05, 1 year 6 months ago Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress Abivax announces presentation of seven abstracts for Obefazimod in ulcerative colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress Abivax Obefazimod Ulcerative Colitis Clinical Trials ECCO
BRIEF published on 01/09/2025 at 17:40, 1 year 7 months ago Abivax Reaches Key Enrollment Milestone in Phase 3 ABTECT Trial Abivax Obefazimod Ulcerative Colitis Phase 3 Trial Clinical Results
PRESS RELEASE published on 01/09/2025 at 17:35, 1 year 7 months ago Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Abivax achieves key milestone in Phase 3 ABTECT trial enrollment with 82% of target participants enrolled for evaluating obefazimod in ulcerative colitis, aiming for NDA submission by H2 2026 Abivax Obefazimod Ulcerative Colitis Phase 3 ABTECT Trial
BRIEF published on 12/23/2024 at 22:10, 1 year 7 months ago Abivax Announces Board Resignation Abivax Obefazimod Board Resignation Truffle Capital Philippe Pouletty
PRESS RELEASE published on 12/23/2024 at 22:05, 1 year 7 months ago Abivax Announces a Change to the Composition of its Board of Directors Abivax announces a change in its Board of Directors composition as Dr. Philippe Pouletty resigns due to new appointment. The company expresses gratitude for his contributions Board Of Directors Resignation Abivax Therapeutics Dr. Philippe Pouletty
BRIEF published on 12/18/2024 at 18:05, 1 year 7 months ago ABIVAX: Share capital and voting rights as of November 30, 2024 Euronext Paris Share Capital Voting Rights Abivax Investment
BRIEF published on 11/27/2024 at 18:05, 1 year 8 months ago ABIVAX: Update of Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights Abivax Financial Transparency
BRIEF published on 11/19/2024 at 22:35, 1 year 8 months ago Abivax Launches ATM Program on Nasdaq Common Shares Biotechnology Funding Nasdaq ATM Program
PRESS RELEASE published on 11/19/2024 at 22:30, 1 year 8 months ago Abivax Establishes an At-the-Market (ATM) Program on Nasdaq Abivax establishes an At-the-Market (ATM) Program on Nasdaq, allowing issuance and sale of ordinary shares to raise up to $150 million. Implementation involves Piper Sandler & Co. as sales agent Ordinary Shares Abivax Nasdaq ATM Program Piper Sandler
BRIEF published on 11/14/2024 at 22:06, 1 year 8 months ago Abivax Releases Q3 2024 Financial Results Financial Results Biotechnology Abivax Ulcerative Colitis Q3 2024
Published on 08/11/2026 at 07:00, 40 minutes ago Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Published on 08/11/2026 at 00:40, 7 hours ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 7 hours 15 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 8 hours 5 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 8 hours 10 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/11/2026 at 07:30, 10 minutes ago STS Group AG's first half of 2026 lays a strong foundation for meeting its full-year targets
Published on 08/11/2026 at 07:30, 10 minutes ago Dermapharm Holding SE reports profitable growth in H1 2026 and confirms guidance
Published on 08/11/2026 at 07:30, 10 minutes ago Salzgitter Group reports encouraging first half of 2026
Published on 08/11/2026 at 07:01, 39 minutes ago NORMA Group delivers significantly higher profitability in the second quarter of 2026; Industry Applications continues to grow
Published on 08/11/2026 at 07:00, 40 minutes ago Infracore SA discloses information on stabilization purchases
Published on 08/10/2026 at 18:00, 13 hours 40 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 19 hours 46 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 20 hours 4 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 22 hours 18 minutes ago Number of shares and voting rights - July 2026 (In French only)
